Joost Huiskens, MD; Karen Bolhuis, MD; Marc R. W. Engelbrecht, MD, PhD; and colleagues in the December issue of the Journal of the American College of Surgeons (JACS) analyzed prospective resectability evaluation of patients with colorectal cancer liver metastases (CRLM) by a panel of radiologists and liver surgeons and found that the high rate of disagreement among experienced liver surgeons reflects the complexity in defining treatment strategies for CRLM and supports the use of a panel rather than a single-surgeon decision.
This article and all other JACS content is available on the JACS website.
